This study examines the relationship between conventional moral belief and drug problem recognition in African-American, Hispanic-American, and non-Hispanic white drug users. After adjustment for demographic, psychosocial, and drug use severity factors that might have confounded this relationship, conventional moral belief was significantly associated with drug problem recognition among African-Americans and Hispanic-Americans but not among whites. The particular relevance of conventional moral belief among nonwhites may reflect cultural values emphasizing collective identity and/or religiosity. Nonwhites may be more inclined than whites to view recovery as a process of claiming or reclaiming moral standing in a community of conventional others.
This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.
Our mission to help improve policy and decisionmaking through research and analysis is enabled through our core values of quality and objectivity and our unwavering commitment to the highest level of integrity and ethical behavior. To help ensure our research and analysis are rigorous, objective, and nonpartisan, we subject our research publications to a robust and exacting quality-assurance process; avoid both the appearance and reality of financial and other conflicts of interest through staff training, project screening, and a policy of mandatory disclosure; and pursue transparency in our research engagements through our commitment to the open publication of our research findings and recommendations, disclosure of the source of funding of published research, and policies to ensure intellectual independence. For more information, visit www.rand.org/about/principles.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.